GLP-1, a type of incretin, is a hormone that plays several essential roles in metabolism
Yet equipped with correct knowledge alongside various existing resources aimed at patient aid, those requiring these transformative medicines have a fair chance at acquiring them without sustaining heavy out-of-pocket expenditures thus enabling full realization of the benefits concomitant with their use
You have a history of diabetes, impaired glucose tolerance, or insulin resistance, given the complex and opposing glycaemic effects of these two agents
In addition to driving weight loss, GLP-1 medications have shown powerful health benefits, including: Lowering cardiovascular risk Improving blood sugar control and insulin sensitivity Reducing inflammation and blood pressure Supporting better outcomes in metabolic syndrome Potential reductions in risk for certain cancers "We're not reacting to trends - we're continuing a legacy," said Mark Bentz, CEO of Red Mountain Weight Loss
Ready to take the next step with a team thats genuinely in your corner
On November 2023, the United States Food and Drug Administration (FDA) has approved Eli Lilly and Company s Zepbound (tirzepatide) injection, the first and only obesity medication to activate both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors